Furthermore, melittin showed anticancer and antiangiogenic effects by suppressing expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) through inhibition of ERK and mTOR pathways in human cervical cancer cells [31]. The gene discussed is HIF1A; the disease is cervical carcinoma.